Nadège Baumlin

Transmembrane Domain Targeting Peptide Antagonizing ErbB2/Neu Inhibits Breast Tumor Growth and Metastasis

Alexia Arpel, Paul Sawma, Caroline Spenlé et al. · Cell Reports · 2014 · 48 citations · Full text

Breast Oncology, Signaling Pathway, Cell Membrane +12

Inhibition of PlexA1-mediated brain tumor growth and tumor-associated angiogenesis using a transmembrane domain targeting peptide

Laurent Jacob, Paul Sawma, Norbert Garnier et al. · Oncotarget · 2016 · 38 citations · Full text

Neuro-oncology, Angiogenesis, Plexin-a1 Expression +15

ACT‐1004‐1239, a first‐in‐class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases

Laetitia Pouzol, Nadège Baumlin, Anna Sassi et al. · The FASEB Journal · 2021 · 36 citations · Full text

Immunology, Immune Regulation, Immunotherapy +19

Inhibition of primary breast tumor growth and metastasis using a neuropilin-1 transmembrane domain interfering peptide

Alexia Arpel, Coralie Gamper, Caroline Spenlé et al. · Oncotarget · 2016 · 33 citations · Full text

Measuring oxidative burden and predicting pharmacological response in coronary artery disease patients with a novel direct activator of haem-free/oxidised sGC

Ingo Ahrens, Jonathon Habersberger, Nadège Baumlin et al. · Atherosclerosis · 2011 · 26 citations · Full text

Novel Direct Activator, Oxidative Burden, Cardiovascular Disease +9